Defibrillation shocks over epicardial patches produce sympathetic neural dysfunction in man

Journal of Cardiovascular Electrophysiology

Volumn 7, Issue 5, 1996, Pages 398-405

  Rigden, Lawrence B ^b   Mitrani, Raul D ^b   Wellman, Henry N ^b   Klein, Lawrence S ^b   Miles, William M ^b   Zipes, Douglas P ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

cardiac sympathetic innervation; epicardial patch electrodes; I 123 MIBG scintigraphy; implantable cardioverter defibrillator

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; AMIODARONE; ATENOLOL; CAPTOPRIL; CLONIDINE; DIGOXIN; FUROSEMIDE; METOPROLOL; NITRATE; PROPRANOLOL; THALLIUM 201;

ADULT; AGED; ARRHYTHMOGENESIS; ARTICLE; AUTONOMIC NEUROPATHY; CARDIOVERSION; CLINICAL ARTICLE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEFIBRILLATION; DEFIBRILLATOR; DIRECT CURRENT; ELECTRODE; EPICARDIUM; FEMALE; HEART ARRHYTHMIA; HEART MUSCLE; HEART SCINTISCANNING; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MALE; PRIORITY JOURNAL; SYMPATHETIC NERVE;

EID: 0029990112     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.1996.tb00545.x     Document Type: Article

References (36)

1. Block M, Breithardt G: Long term follow-up and clinical results of implantable cardioverter-defibrillators. In Zipes DP, Jalife J, eds: Cardiac Electrophysiology: From Cell to Bedside. WB Saunders Co., Philadelphia, 1995, pp. 1412-1425.
2. Zipes DP, Roberts D, for the PCD Investigators: Results of the world wide study of the implantable cardioverter-defibrillator: A comparison of epicardial and endocardial lead systems. Circulation 1995;92:59-65.
3. Furman S, Kim SG: The present status of implantable cardiovascular defibrillator therapy. J Cardiovasc Electrophysiol 1991;14:1846-1849.
4. Kim SG, Fisher JD, Furman S, et al: Exacerbation of ventricular arrhythmias during the postoperative period after implantation of an automatic defibrillator. J Am Coll Cardiol 1992;18:1200-1206.
5. Marchlinski FE, Flores BT, Buxton AE, et al: The automatic implantable cardioverter-defibrillator: Efficacy, complications, and device failures. Ann Intern Med 1986;104:481-488.
6. Bardy GH, Hofer H, Johnson G, et al: Implantable transvenous cardioverter-defibrillators. Circulation 1993;87:1152-1168.
7. Gartman DM, Bardy GH, Allen M, et al: Short term morbidity and mortality of implantation of automatic implantable cardioverter-defibrillator. J Thorac Cardiovasc Surg 1990;100:353-359.
8. Kim SG, Ling J, Fisher JD, et al: Comparison and frequency of ventricular arrhythmias after defibrillator implantation by thoracotomy versus nonthoracotomy approaches. Am J Cardiol 1994;74:1245-1248.
9. Ong JC, Hsu PC, Lin L, et al: Arrhythmia after cardioverter-defibrillator implantation: Comparison of epicardial and transvenous lead systems. Am J Cardiol 1995;75:137-140.
10. Martins JB, Zipes DP: Epicardial phenol interrupts refractory period responses to sympathetic but not vagal stimulation in canine left ventricular epicardium and endocardium. Circ Res 1980;47:33-40.
11. Takahashi N, Barber MJ, Zipes DP: Efferent vagal innervation of the canine ventricle. Am J Physiol 1985;248:H89-H97.
12. Ito M, Pride HP, Zipes DP: Defibrillating shocks delivered to the heart impair efferent sympathetic responsiveness. Circulation 1993;88:2661-2673.
13. Kline RC, Swanson DP, Weiland DM: Myocardial imaging in man with I-123-metaiodobenzylguanidine. J Nucl Med 1981;22:129-132.
14. Dae MW, Botvinick EH: Imaging of the heart using metaiodobenzylguanidine. J Thorac Imaging 1990; 5:31-36.
15. Wellman HN, Zipes DP: Cardiac sympathetic imaging with radioiodinated metaiodobenzylguanidine (MIBG). Prog Cardiol 1990;3:161-174.
16. Nakajo M, Copp J, Kalff V, et al: The normal and abnormal distribution of the adrenomedullary imaging agent m-(I-131) iodobenzylguanidine (I-131 mIBG) in man: Evaluation by scintigraphy. J Nucl Med 1983;24:672-682.
17. Sisson JC, Johnson J, Bolgos G, et al: Portrayal of adrenergic denervation in the presence of myocardial infarction: A feasibility study. Am J Physiol Imaging 1990;5:151-166.
18. Minardo JD, Tuli MM, Mock BH, et al: Scintigraphic and electrophysiologic evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application. Circulation 1988;78:1008-1019.
19. Stanton MS, Tuli MM, Radtke ML, et al: Regional sympathetic denervation after myocardial infarction in humans detected noninvasively using I-123-metaiodobenzylguanidine. J Am Coll Cardiol 1989; 14:1519-1526.
20. McGhie AI, Orbett JR, Akers MS, et al: Regional cardiac adrenergic function using I-123-metaiodobenzylguanidine tomographic imaging after acute myocardial infarction. Am J Cardiol 1991;67:236-242.
21. Wharton JM, Friedman IM, Greenfield RA, et al: Quantitative perfusion and sympathetic nerve size after myocardial infarction in humans. (Abstract) J Am Coll Cardiol 1992;19(Suppl A):264A.
22. Khafagi FA, Shapiro B, Fig LM, et al: Labetolol reduces Iodine-131 MIBG uptake by pheochromocytoma and normal tissue. J Nucl Med 1989;30:481-489.
23. Mock BH, Weiner RE: Simplified solid-state labeling of I-123-metaiodobenzylguanidine. Appl Radiat Isot 1988;39:939-942.
24. Tadeschi CG, White CW: A morphologic study of canine hearts subjected to fibrillation, electrical defibrillation, and manual compression. Circulation 1954; 9:916-921.
25. Dahl CD, Ewy GA, Warner ED, et al: Myocardial necrosis from direct current countershock. Circulation 1974;50:956-961.
26. Warner ED, Dahl CD, Ewy GA: Myocardial injury from transthoracic defibrillator countershock. Arch Pathol 1975;99:55-59.
27. Ehsani A, Ewy GA, Sobel BE: Effects of electrical countershock on serum creatinine phosphokinase (CPK) isoenzyme activity. Am J Cardiol 1976;37:12-18.
28. Doherty PW, McLaughlin PR, Billingham M, et al: Cardiac damage produced by direct current countershock applied to the heart. Am J Cardiol 1979;43:225-232.
29. Dicola VC, Freedman GS, Downing SE, et al: Myocardial uptake of technetium-99m stannous pyrophosphate following direct current transthoracic countershock. Circulation 1976;54:980-986.
30. Singer I, Hutchins BM, Mirowski M, et al: Pathologic findings related to the lead system and cardioverter-defibrillator. J Am Coll Cardiol 1987;10:382-388.
31. Henderson EB, Kahn JK, Corbett JR, et al: Abnormal I-123-metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy. Circulation 1988;78:1192-1199.
32. Schofer J, Spielmann R, Schuchert A, et al: Iodine-123-meta-iodobenzylguanidine scintigraphy: A noninvasive method to demonstrate myocardial adrenergic nervous system disintegrity in patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 1988; 12:1252-1258.
33. Inoue H, Zipes DP: Results of sympathetic denervation in the canine heart: Supersensitivity that may be arrhythmogenic. Circulation 1987;75:877-887.
34. Kammerling JJ, Green FJ, Watanabe AM, et al: Denervation supersensitivity of refractoriness in noninfarcted areas apical to transmural myocardial infarction. Circulation 1987;76:383-393.
35. Zipes DP: Sympathetic stimulation and arrhythmias. (Editorial) N Engl J Med 1991;325:656-657.
36. Mitrani RD, Klein LS, Miles WM, et al: Regional cardiac sympathetic denervation in patients with ventricular tachycardia in the absence of coronary artery disease. J Am Coll Cardiol 1993;22:1344-1353.